Recently, new molecular targets have been confirmed and various targeted agents are now being investigated for the treatment of HCC.

This advancement represents a breakthrough in the management of this complex disease, and proves that molecular targeted therapies can be effective in this otherwise chemo-resistant tumor.

This review attempts to concisely summarize the molecularly targeted therapy of advanced hepatocellular carcinoma.